Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contrast Media | 10 | 2025 | 492 | 1.550 |
Why?
|
| Nanoparticles | 7 | 2025 | 293 | 1.120 |
Why?
|
| Models, Anatomic | 3 | 2020 | 107 | 1.110 |
Why?
|
| Computer-Aided Design | 2 | 2020 | 19 | 1.060 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2026 | 2130 | 0.830 |
Why?
|
| Printing, Three-Dimensional | 2 | 2020 | 88 | 0.730 |
Why?
|
| Indocyanine Green | 3 | 2023 | 54 | 0.710 |
Why?
|
| Optical Imaging | 2 | 2018 | 76 | 0.650 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2021 | 90 | 0.640 |
Why?
|
| X-Ray Microtomography | 3 | 2021 | 101 | 0.630 |
Why?
|
| Neuroblastoma | 2 | 2021 | 557 | 0.550 |
Why?
|
| Child Abuse | 1 | 2021 | 223 | 0.540 |
Why?
|
| Phantoms, Imaging | 2 | 2018 | 149 | 0.540 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2021 | 398 | 0.480 |
Why?
|
| Computer Peripherals | 1 | 2013 | 4 | 0.410 |
Why?
|
| Musculoskeletal Diseases | 1 | 2013 | 56 | 0.390 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 242 | 0.360 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 487 | 0.350 |
Why?
|
| Pediatrics | 1 | 2020 | 1243 | 0.330 |
Why?
|
| Aortic Aneurysm | 2 | 2025 | 224 | 0.320 |
Why?
|
| Aortic Rupture | 2 | 2021 | 114 | 0.300 |
Why?
|
| Hepatoblastoma | 2 | 2022 | 196 | 0.290 |
Why?
|
| Placenta | 3 | 2019 | 526 | 0.290 |
Why?
|
| Gadolinium | 3 | 2019 | 112 | 0.270 |
Why?
|
| Mice | 17 | 2025 | 18394 | 0.270 |
Why?
|
| Moyamoya Disease | 2 | 2025 | 43 | 0.260 |
Why?
|
| Animals | 21 | 2025 | 34262 | 0.250 |
Why?
|
| Liver Neoplasms | 3 | 2022 | 1405 | 0.230 |
Why?
|
| Oxidative Phosphorylation | 1 | 2025 | 130 | 0.220 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2025 | 186 | 0.200 |
Why?
|
| Actins | 1 | 2025 | 317 | 0.200 |
Why?
|
| Tumor Burden | 2 | 2021 | 241 | 0.190 |
Why?
|
| Rhabdomyosarcoma | 1 | 2026 | 228 | 0.190 |
Why?
|
| Angiography | 2 | 2021 | 188 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 3931 | 0.180 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2022 | 78 | 0.180 |
Why?
|
| Mouth Neoplasms | 1 | 2023 | 98 | 0.180 |
Why?
|
| Aorta | 2 | 2025 | 530 | 0.170 |
Why?
|
| Indans | 1 | 2021 | 53 | 0.170 |
Why?
|
| Iodine Radioisotopes | 1 | 2021 | 65 | 0.170 |
Why?
|
| Radiometry | 1 | 2021 | 52 | 0.170 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2023 | 157 | 0.170 |
Why?
|
| Oxadiazoles | 1 | 2021 | 25 | 0.170 |
Why?
|
| Triiodobenzoic Acids | 1 | 2021 | 30 | 0.170 |
Why?
|
| Hospitals, Community | 1 | 2021 | 52 | 0.170 |
Why?
|
| Disposable Equipment | 1 | 2020 | 16 | 0.170 |
Why?
|
| Cerebrovascular Disorders | 1 | 2021 | 114 | 0.160 |
Why?
|
| Aortography | 1 | 2021 | 153 | 0.160 |
Why?
|
| alpha-Synuclein | 1 | 2021 | 139 | 0.160 |
Why?
|
| Natural Language Processing | 1 | 2021 | 77 | 0.160 |
Why?
|
| Nasopharynx | 1 | 2020 | 87 | 0.160 |
Why?
|
| Disease Models, Animal | 8 | 2025 | 4691 | 0.160 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 162 | 0.160 |
Why?
|
| Liposomes | 5 | 2019 | 201 | 0.160 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2020 | 51 | 0.160 |
Why?
|
| Cytosol | 1 | 2019 | 139 | 0.150 |
Why?
|
| Iodine | 2 | 2016 | 23 | 0.150 |
Why?
|
| Muscle, Skeletal | 1 | 2026 | 1002 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2021 | 214 | 0.150 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 703 | 0.150 |
Why?
|
| Piperazines | 1 | 2021 | 273 | 0.150 |
Why?
|
| Hindlimb | 1 | 2018 | 73 | 0.140 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 388 | 0.140 |
Why?
|
| Computer Simulation | 1 | 2021 | 681 | 0.140 |
Why?
|
| Integrin alpha4beta1 | 1 | 2018 | 26 | 0.140 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 2364 | 0.140 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2017 | 65 | 0.130 |
Why?
|
| Child | 6 | 2026 | 26361 | 0.130 |
Why?
|
| Chickens | 1 | 2017 | 271 | 0.130 |
Why?
|
| Machine Learning | 1 | 2021 | 378 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 602 | 0.130 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 361 | 0.130 |
Why?
|
| Skull | 1 | 2018 | 154 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2021 | 564 | 0.130 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2017 | 26 | 0.120 |
Why?
|
| Osteotomy | 1 | 2017 | 47 | 0.120 |
Why?
|
| Cattle | 1 | 2017 | 503 | 0.120 |
Why?
|
| Humans | 17 | 2026 | 132041 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 705 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 234 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 738 | 0.120 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 146 | 0.120 |
Why?
|
| Echo-Planar Imaging | 1 | 2016 | 21 | 0.120 |
Why?
|
| Algorithms | 2 | 2021 | 1690 | 0.120 |
Why?
|
| Dog Diseases | 1 | 2016 | 58 | 0.120 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2016 | 135 | 0.110 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2014 | 11 | 0.110 |
Why?
|
| DNA | 1 | 2019 | 1440 | 0.110 |
Why?
|
| Cerebral Arteries | 1 | 2014 | 80 | 0.100 |
Why?
|
| Amyloid | 1 | 2014 | 76 | 0.100 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 874 | 0.100 |
Why?
|
| Electronic Health Records | 1 | 2021 | 815 | 0.100 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 84 | 0.100 |
Why?
|
| Blood-Brain Barrier | 1 | 2014 | 151 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2025 | 4733 | 0.100 |
Why?
|
| Stroke | 1 | 2021 | 1051 | 0.100 |
Why?
|
| Fetus | 1 | 2016 | 585 | 0.090 |
Why?
|
| Female | 13 | 2026 | 71380 | 0.090 |
Why?
|
| Brain | 2 | 2015 | 3251 | 0.090 |
Why?
|
| Uterus | 1 | 2016 | 547 | 0.090 |
Why?
|
| Electron Microscope Tomography | 1 | 2012 | 24 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1615 | 0.090 |
Why?
|
| Equipment Design | 1 | 2013 | 557 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2026 | 15089 | 0.090 |
Why?
|
| Cytoskeleton | 1 | 2012 | 166 | 0.080 |
Why?
|
| Male | 9 | 2026 | 65425 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2021 | 4696 | 0.080 |
Why?
|
| Cryoelectron Microscopy | 1 | 2012 | 239 | 0.080 |
Why?
|
| Infant | 2 | 2026 | 13343 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 1011 | 0.070 |
Why?
|
| Ligands | 2 | 2021 | 487 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2021 | 555 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2022 | 3703 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2021 | 3864 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2026 | 17748 | 0.060 |
Why?
|
| Heterografts | 2 | 2017 | 195 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 1000 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 1547 | 0.060 |
Why?
|
| Niacinamide | 1 | 2025 | 30 | 0.060 |
Why?
|
| Neoplasms | 1 | 2020 | 2968 | 0.060 |
Why?
|
| United States | 1 | 2021 | 11846 | 0.060 |
Why?
|
| Particle Size | 1 | 2025 | 137 | 0.050 |
Why?
|
| Disease Progression | 2 | 2021 | 2229 | 0.050 |
Why?
|
| Glycolysis | 1 | 2025 | 171 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2025 | 232 | 0.050 |
Why?
|
| Body Composition | 1 | 2026 | 550 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2018 | 1062 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2023 | 251 | 0.040 |
Why?
|
| Cell Movement | 1 | 2025 | 882 | 0.040 |
Why?
|
| Protein Aggregates | 1 | 2021 | 43 | 0.040 |
Why?
|
| Liver | 2 | 2021 | 1805 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2021 | 80 | 0.040 |
Why?
|
| Protein Folding | 1 | 2021 | 216 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 316 | 0.040 |
Why?
|
| Survival Rate | 1 | 2026 | 2154 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2021 | 195 | 0.040 |
Why?
|
| Drug Design | 1 | 2021 | 164 | 0.040 |
Why?
|
| Pregnancy | 3 | 2019 | 7588 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2021 | 135 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2021 | 192 | 0.040 |
Why?
|
| Mitochondria | 1 | 2025 | 766 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 381 | 0.040 |
Why?
|
| Adult | 1 | 2020 | 31747 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 264 | 0.040 |
Why?
|
| Placentation | 1 | 2019 | 59 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 831 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2018 | 96 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1625 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 344 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 89 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2025 | 1950 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 302 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 713 | 0.030 |
Why?
|
| Models, Animal | 1 | 2019 | 460 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2021 | 1474 | 0.030 |
Why?
|
| Meglumine | 1 | 2016 | 16 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 580 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2017 | 817 | 0.030 |
Why?
|
| Orthopedics | 1 | 2017 | 78 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2016 | 111 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2016 | 82 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 2315 | 0.030 |
Why?
|
| Dogs | 1 | 2016 | 623 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2020 | 760 | 0.030 |
Why?
|
| Gestational Age | 1 | 2019 | 1236 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 1147 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1863 | 0.030 |
Why?
|
| Protein Binding | 1 | 2018 | 1674 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 986 | 0.030 |
Why?
|
| Down Syndrome | 1 | 2017 | 233 | 0.030 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2014 | 114 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 2020 | 0.020 |
Why?
|
| Mammary Glands, Animal | 1 | 2016 | 447 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5124 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 3458 | 0.020 |
Why?
|
| Time Factors | 1 | 2021 | 6283 | 0.020 |
Why?
|
| Lung | 1 | 2016 | 1579 | 0.020 |
Why?
|
| Adolescent | 1 | 2026 | 21018 | 0.020 |
Why?
|
| Software | 1 | 2012 | 753 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 11020 | 0.020 |
Why?
|